A- A A+

U.S. cannabis laws projected to cost generic and brand pharmaceutical firms billions. 

Bednarek Z, Doremus JM, Stith SS (2022) 

PLoS ONE 17(8): e0272492. doi.org/10.1371/journal.pone.0272492

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0272492